Detailed TOC of Global Artificial Blood Market Research Report 2026
1 Market Overview
1.1 Artificial Blood Product Introduction
1.2 Global Artificial Blood Market Size Forecast
1.3 Artificial Blood Market Trends & Drivers
1.3.1 Artificial Blood Industry Trends
1.3.2 Artificial Blood Market Drivers & Opportunity
1.3.3 Artificial Blood Market Challenges
1.3.4 Artificial Blood Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Artificial Blood Players Revenue Ranking (2025)
2.2 Global Artificial Blood Revenue by Company (2021-2026)
2.3 Key Companies Artificial Blood Manufacturing Base Distribution and Headquarters
2.4 Key Companies Artificial Blood Product Offered
2.5 Key Companies Time to Begin Mass Production of Artificial Blood
2.6 Artificial Blood Market Competitive Analysis
2.6.1 Artificial Blood Market Concentration Rate (2021-2026)
2.6.2 Global 5 and 10 Largest Companies by Artificial Blood Revenue in 2025
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Blood as of 2025)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Human Blood
3.1.2 Synthetic Blood
3.1.3 Animal Blood
3.2 Global Artificial Blood Sales Value by Type
3.2.1 Global Artificial Blood Sales Value by Type (2021 VS 2025 VS 2035)
3.2.2 Global Artificial Blood Sales Value, by Type (2021-2035)
3.2.3 Global Artificial Blood Sales Value, by Type (%) (2021-2035)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hemoglobin-Based Oxygen Carriers (HBOCs)
4.1.2 Perflurocarbon Emulsions (PFCEs)
4.2 Global Artificial Blood Sales Value by Application
4.2.1 Global Artificial Blood Sales Value by Application (2021 VS 2025 VS 2035)
4.2.2 Global Artificial Blood Sales Value, by Application (2021-2035)
4.2.3 Global Artificial Blood Sales Value, by Application (%) (2021-2035)
5 Segmentation by Region
5.1 Global Artificial Blood Sales Value by Region
5.1.1 Global Artificial Blood Sales Value by Region: 2021 VS 2025 VS 2035
5.1.2 Global Artificial Blood Sales Value by Region (2021-2026)
5.1.3 Global Artificial Blood Sales Value by Region (2026-2035)
5.1.4 Global Artificial Blood Sales Value by Region (%), (2021-2035)
5.2 North America
5.2.1 North America Artificial Blood Sales Value, 2021-2035
5.2.2 North America Artificial Blood Sales Value by Country (%), 2025 VS 2035
5.3 Europe
5.3.1 Europe Artificial Blood Sales Value, 2021-2035
5.3.2 Europe Artificial Blood Sales Value by Country (%), 2025 VS 2035
5.4 Asia Pacific
5.4.1 Asia Pacific Artificial Blood Sales Value, 2021-2035
5.4.2 Asia Pacific Artificial Blood Sales Value by Country (%), 2025 VS 2035
5.5 South America
5.5.1 South America Artificial Blood Sales Value, 2021-2035
5.5.2 South America Artificial Blood Sales Value by Country (%), 2025 VS 2035
5.6 Middle East & Africa
5.6.1 Middle East & Africa Artificial Blood Sales Value, 2021-2035
5.6.2 Middle East & Africa Artificial Blood Sales Value by Country (%), 2025 VS 2035
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Artificial Blood Sales Value Growth Trends, 2021 VS 2025 VS 2035
6.2 Key Countries/Regions Artificial Blood Sales Value
6.3 United States
6.3.1 United States Artificial Blood Sales Value, 2021-2035
6.3.2 United States Artificial Blood Sales Value by Type (%), 2025 VS 2035
6.3.3 United States Artificial Blood Sales Value by Application, 2025 VS 2035
6.4 Europe
6.4.1 Europe Artificial Blood Sales Value, 2021-2035
6.4.2 Europe Artificial Blood Sales Value by Type (%), 2025 VS 2035
6.4.3 Europe Artificial Blood Sales Value by Application, 2025 VS 2035
6.5 China
6.5.1 China Artificial Blood Sales Value, 2021-2035
6.5.2 China Artificial Blood Sales Value by Type (%), 2025 VS 2035
6.5.3 China Artificial Blood Sales Value by Application, 2025 VS 2035
6.6 Japan
6.6.1 Japan Artificial Blood Sales Value, 2021-2035
6.6.2 Japan Artificial Blood Sales Value by Type (%), 2025 VS 2035
6.6.3 Japan Artificial Blood Sales Value by Application, 2025 VS 2035
6.7 South Korea
6.7.1 South Korea Artificial Blood Sales Value, 2021-2035
6.7.2 South Korea Artificial Blood Sales Value by Type (%), 2025 VS 2035
6.7.3 South Korea Artificial Blood Sales Value by Application, 2025 VS 2035
6.8 Southeast Asia
6.8.1 Southeast Asia Artificial Blood Sales Value, 2021-2035
6.8.2 Southeast Asia Artificial Blood Sales Value by Type (%), 2025 VS 2035
6.8.3 Southeast Asia Artificial Blood Sales Value by Application, 2025 VS 2035
6.9 India
6.9.1 India Artificial Blood Sales Value, 2021-2035
6.9.2 India Artificial Blood Sales Value by Type (%), 2025 VS 2035
6.9.3 India Artificial Blood Sales Value by Application, 2025 VS 2035
7 Company Profiles
7.1 Aurum Biosciences Ltd.
7.1.1 Aurum Biosciences Ltd. Profile
7.1.2 Aurum Biosciences Ltd. Main Business
7.1.3 Aurum Biosciences Ltd. Artificial Blood Products, Services and Solutions
7.1.4 Aurum Biosciences Ltd. Artificial Blood Revenue (US$ Million) & (2021-2026)
7.1.5 Aurum Biosciences Ltd. Recent Developments
7.2 HEMARINA SA
7.2.1 HEMARINA SA Profile
7.2.2 HEMARINA SA Main Business
7.2.3 HEMARINA SA Artificial Blood Products, Services and Solutions
7.2.4 HEMARINA SA Artificial Blood Revenue (US$ Million) & (2021-2026)
7.2.5 HEMARINA SA Recent Developments
7.3 HbO2 Therapeutics
7.3.1 HbO2 Therapeutics Profile
7.3.2 HbO2 Therapeutics Main Business
7.3.3 HbO2 Therapeutics Artificial Blood Products, Services and Solutions
7.3.4 HbO2 Therapeutics Artificial Blood Revenue (US$ Million) & (2021-2026)
7.3.5 KaloCyte Inc. Recent Developments
7.4 KaloCyte Inc.
7.4.1 KaloCyte Inc. Profile
7.4.2 KaloCyte Inc. Main Business
7.4.3 KaloCyte Inc. Artificial Blood Products, Services and Solutions
7.4.4 KaloCyte Inc. Artificial Blood Revenue (US$ Million) & (2021-2026)
7.4.5 KaloCyte Inc. Recent Developments
7.5 SpheriTech Ltd.
7.5.1 SpheriTech Ltd. Profile
7.5.2 SpheriTech Ltd. Main Business
7.5.3 SpheriTech Ltd. Artificial Blood Products, Services and Solutions
7.5.4 SpheriTech Ltd. Artificial Blood Revenue (US$ Million) & (2021-2026)
7.5.5 SpheriTech Ltd. Recent Developments
7.6 NuvOx Pharma
7.6.1 NuvOx Pharma Profile
7.6.2 NuvOx Pharma Main Business
7.6.3 NuvOx Pharma Artificial Blood Products, Services and Solutions
7.6.4 NuvOx Pharma Artificial Blood Revenue (US$ Million) & (2021-2026)
7.6.5 NuvOx Pharma Recent Developments
8 Industry Chain Analysis
8.1 Artificial Blood Industrial Chain
8.2 Artificial Blood Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Artificial Blood Sales Model
8.5.2 Sales Channel
8.5.3 Artificial Blood Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
